UPLOAD Filing
AlphaTON Capital Corp
Date: May 8, 2025 · CIK: 0001095435 · Accession: 0000000000-25-004906
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-28696
Letter
Re: Portage Biotech Inc. Registration Statement on Form F-3 Filed May 5, 2025 File No. 333-28696 Dear Alexander Pickett:
May 8, 2025
Alexander Pickett Chief Executive Officer Portage Biotech Inc. Clarence Thomas Building, P.O. Box 4649 Road Town, Tortola, British Virgin Islands, VG1110
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Andrew D. Hudders, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> May 8, 2025 Alexander Pickett Chief Executive Officer Portage Biotech Inc. Clarence Thomas Building, P.O. Box 4649 Road Town, Tortola, British Virgin Islands, VG1110 Re: Portage Biotech Inc. Registration Statement on Form F-3 Filed May 5, 2025 File No. 333-28696 Dear Alexander Pickett: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Andrew D. Hudders, Esq. </TEXT> </DOCUMENT>